Basel Medical Group Ltd Ordinary Shares (BMGL) vs Imunon, Inc. (IMNN)
A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Imunon, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMGL
Basel Medical Group Ltd Ordinary Shares
$3.32HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
IMNN
Imunon, Inc.
$1.21HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — BMGL vs IMNN
growth of $100 · dividends reinvested · last 2yBMGL -94.1% (-75.6%/yr)IMNN -90.1% (-68.5%/yr)IMNN compounded faster over this window
BMGL IMNN
BMGL vs IMNN: by the numbers
- •BMGL is the larger company ($5M vs $5M market cap).
- •Both run net losses; IMNN's is the smaller (0.00% vs -106.78% net margin).
Metrics side by side
Valuation
| Metric | BMGL | IMNN |
|---|---|---|
| P/B ratio | 1.07 | 1.21 |
Profitability
| Metric | BMGL | IMNN |
|---|---|---|
| Gross margin | 77.68% | 0.00% |
| Operating margin | -19.28% | 0.00% |
| Net margin | -106.78% | 0.00% |
| ROE | -248.66% | -351.30% |
| ROIC | -35.07% | -126.69% |
Growth (annualized)
| Metric | BMGL | IMNN |
|---|---|---|
| Total return CAGR (5Y) | N/A | -63.83% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.